Dr Nathan Kerr was featured by Bloomberg for research of the PolyActiva implant.

The PolyActiva implant, undergoing clinical trials, slowly releases glaucoma medication and may reduce or eliminate the need for daily eye drops.

Dr Nathan Kerr with the world’s first PolyActiva implant recipient.